The global immunoassay market is projected to grow significantly, driven by advancements in enzyme immunoassays, which held over 58.2% market share in 2022. The infectious disease testing segment is expected to expand at a CAGR of 5.6%, fueled by rising global incidences of diseases like HIV and hepatitis. North America leads the market with over 36.2% of revenues, supported by advanced healthcare infrastructure and a high prevalence of chronic diseases.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
